Publications by authors named "J Hartl"

Despite abundant genomic and phenotypic data across individuals and environments, the functional impact of most mutations on phenotype remains unclear. Here, we bridge this gap by linking genome to proteome in 800 meiotic progeny from an intercross between two closely related isolates adapted to distinct niches. Modest genetic distance between the parents generated remarkable proteomic diversity that was amplified in the progeny and captured by 6,476 genotype-protein associations, over 1,600 of which we resolved to single variants.

View Article and Find Full Text PDF

Patients with primary biliary cholangitis (PBC) suffer from a variety of physical complaints such as fatigue, itching or joint pain. Since little is known about the experience of symptoms and the corresponding coping strategies in this patient group, a qualitative study was conducted in which 15 patients with PBC were interviewed. The patients reported being burdened by numerous physical complaints, some of which require extensive coping and adaptation processes.

View Article and Find Full Text PDF

Pro-inflammatory autoantigen-specific CD4 T helper (auto-Th) cells are central orchestrators of autoimmune diseases (AIDs). We aimed to characterize these cells in human AIDs with defined autoantigens by combining human leukocyte antigen (HLA)-tetramer-based and activation-based multidimensional ex vivo analyses. In aquaporin4-antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD) patients, auto-Th cells expressed CD154, but proliferative capacity and pro-inflammatory cytokines were strongly reduced.

View Article and Find Full Text PDF
Article Synopsis
  • In autoimmune hepatitis, achieving complete biochemical remission (CBR) is difficult with standard thiopurine dosing, prompting a study on optimizing thiopurine metabolite levels for better treatment outcomes.
  • Analysis of 337 patients revealed that stable CBR correlates with higher levels of the active metabolite 6-thioguanine nucleotides (6TGN), with an optimal threshold of ≥223 pmol/0.2 mL linked to successful remission maintenance.
  • Increasing azathioprine doses tends to promote the formation of a toxic metabolite (6-methylmercaptopurine), but combining allopurinol with low-dose thiopurines significantly raised 6TGN levels and decreased 6M
View Article and Find Full Text PDF